Tenon Medical

Q2 FY2026 EarningsQ2 FY26 missed consensus estimates across key financial metrics despite strong top-line growth. Revenue of $1.3M came in 15.6% below the expected $1.5M, while gross margin of 64% missed the 68% target by 4.00pct. GAAP EPS of -$12.35 was significantly worse than the consensus expectation of -$8.40, primarily driven by higher-than-expected operating expenses and $0.9M in non-cash interest related to convertible notes. Despite these misses, surgical case volumes reached record highs in July, providing a potential positive catalyst for H2 FY26.